Search Results

There are 5953 results for: content related to: Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen–positive myeloid cell infiltration in mice

  1. You have free access to this content
    Experimental Hepatocarcinogenesis

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1057A–1091A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26879

  2. You have free access to this content
    CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice

    Hepatology

    Volume 61, Issue 5, May 2015, Pages: 1591–1602, Yunching Chen, Rakesh R. Ramjiawan, Thomas Reiberger, Mei R. Ng, Tai Hato, Yuhui Huang, Hiroki Ochiai, Shuji Kitahara, Elizabeth C. Unan, Tejaswini P. Reddy, Christopher Fan, Peigen Huang, Nabeel Bardeesy, Andrew X. Zhu, Rakesh K. Jain and Dan G. Duda

    Version of Record online : 20 MAR 2015, DOI: 10.1002/hep.27665

  3. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  4. Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 12, December 2013, Pages: 1834–1841, Daisuke Miyaki, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Ayako Urabe, Keiichi Masaki, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Takashi Nakahara, Tomokazu Kawaoka, Akira Hiramatsu, Shoichi Takahashi, Masaki Ishikawa, Hideaki Kakizawa, Kazuo Awai and Kazuaki Chayama

    Version of Record online : 22 NOV 2013, DOI: 10.1111/jgh.12311

  5. You have free access to this content
    Effects of Antitumor Drug Sorafenib on Chick Embryo Development

    The Anatomical Record

    Volume 298, Issue 7, July 2015, Pages: 1271–1281, Yi-Sen Cheng, Xiao-Yu Wang, Guang Wang, Yan Li, Yue-Lei Chen, Man-li Chuai, Kenneth Ka Ho Lee, Xiao-Yan Ding and Xue-song Yang

    Version of Record online : 17 APR 2015, DOI: 10.1002/ar.23155

  6. You have full text access to this OnlineOpen article
    Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 2, February 2015, Pages: 430–441, Eva Juengel, Dana Kim, Jasmina Makarević, Michael Reiter, Igor Tsaur, Georg Bartsch, Axel Haferkamp and Roman A. Blaheta

    Version of Record online : 2 DEC 2014, DOI: 10.1111/jcmm.12471

  7. You have free access to this content
    Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes

    Hepatology

    Volume 53, Issue 5, May 2011, Pages: 1708–1718, Yue-Lei Chen, Jing Lv, Xiao-Lei Ye, Ming-Yu Sun, Qin Xu, Cheng-Hai Liu, Li-Hua Min, Hui-Ping Li, Ping Liu and Xiaoyan Ding

    Version of Record online : 22 APR 2011, DOI: 10.1002/hep.24254

  8. You have free access to this content
    Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial

    International Journal of Cancer

    Volume 132, Issue 10, 15 May 2013, Pages: 2448–2458, Young-Hwa Chung, Guohong Han, Jung-Hwan Yoon, Jijin Yang, Jianhua Wang, Guo-Liang Shao, Byung Ik Kim, Teng-Yu Lee and Yee Chao

    Version of Record online : 28 NOV 2012, DOI: 10.1002/ijc.27925

  9. Sorafenib-induced premalignant and malignant skin lesions

    International Journal of Dermatology

    Volume 50, Issue 4, April 2011, Pages: 396–402, Victoria L. Williams, Philip R. Cohen and David J. Stewart

    Version of Record online : 18 MAR 2011, DOI: 10.1111/j.1365-4632.2010.04822.x

  10. You have full text access to this OnlineOpen article
    Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1434–1444, Floris H. Groenendijk, Wouter W. Mellema, Eline van der Burg, Eva Schut, Michael Hauptmann, Hugo M. Horlings, Stefan M. Willems, Michel M. van den Heuvel, Jos Jonkers, Egbert F. Smit and René Bernards

    Version of Record online : 8 AUG 2014, DOI: 10.1002/ijc.29113

  11. You have free access to this content
    A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options

    BJU International

    Volume 107, Issue 8, April 2011, Pages: 1190–1199, Joaquim Bellmunt, Tim Eisen, Cezary Szczylik, Peter Mulders and Camillo Porta

    Version of Record online : 15 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09829.x

  12. You have free access to this content
    ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21(CIP1/WAF1) in human cancer cells

    British Journal of Pharmacology

    Volume 171, Issue 13, July 2014, Pages: 3182–3195, Jingru Li, Yicheng Chen, Jiali Wan, Xin Liu, Chunrong Yu and Wenhua Li

    Version of Record online : 10 JUN 2014, DOI: 10.1111/bph.12659

  13. You have free access to this content
    Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1245–1256, Marc Mejias, Ester Garcia-Pras, Carolina Tiani, Rosa Miquel, Jaime Bosch and Mercedes Fernandez

    Version of Record online : 25 NOV 2008, DOI: 10.1002/hep.22758

  14. You have full text access to this OnlineOpen article
    FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity

    Pharmacology Research & Perspectives

    Volume 3, Issue 5, October 2015, Dilruba Ahmed, Petra J. de Verdier, Charlotta Ryk, Oscar Lunqe, Per Stål and Jenny Flygare

    Version of Record online : 19 AUG 2015, DOI: 10.1002/prp2.171

  15. Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan

    Liver International

    Volume 35, Issue 5, May 2015, Pages: 1581–1589, Haruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, Kaoru Tsuchiya, Kouji Joko, Chikara Ogawa, Hiroyoshi Taniguchi, Etsuro Orito, Yasushi Uchida, Namiki Izumi and Japanese Red Cross Liver Study Group

    Version of Record online : 9 JUN 2014, DOI: 10.1111/liv.12591

  16. You have free access to this content
    Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib

    Hepatology

    Volume 56, Issue 6, December 2012, Pages: 2363–2374, Carlo Spirli, Carola M. Morell, Luigi Locatelli, Stefano Okolicsanyi, Cecilia Ferrero, Amy K. Kim, Luca Fabris, Romina Fiorotto and Mario Strazzabosco

    Version of Record online : 27 AUG 2012, DOI: 10.1002/hep.25872

  17. On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study

    Alimentary Pharmacology & Therapeutics

    Volume 45, Issue 8, April 2017, Pages: 1146–1155, J. Howell, D. J. Pinato, R. Ramaswami, D. Bettinger, T. Arizumi, C. Ferrari, C. Yen, A. Gibbin, M. E. Burlone, G. Guaschino, L. Sellers, J. Black, M. Pirisi, M. Kudo, R. Thimme, J.-W. Park and R. Sharma

    Version of Record online : 2 MAR 2017, DOI: 10.1111/apt.13977

  18. Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth

    Pediatric Blood & Cancer

    Volume 59, Issue 4, October 2012, Pages: 642–647, Nisha C. Kakodkar, Radhika R. Peddinti, Yufeng Tian, Lisa J. Guerrero, Alexandre Chlenski, Qiwei Yang, Helen R. Salwen, Michael L. Maitland and Susan L. Cohn

    Version of Record online : 6 DEC 2011, DOI: 10.1002/pbc.24004

  19. You have free access to this content
    Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma

    Hepatology

    Volume 59, Issue 1, January 2014, Pages: 190–201, Wei-Tien Tai, Chung-Wai Shiau, Pei-Jer Chen, Pei-Yi Chu, Hsiang-Po Huang, Chun-Yu Liu, Jui-Wen Huang and Kuen-Feng Chen

    Version of Record online : 9 DEC 2013, DOI: 10.1002/hep.26640

    Corrected by:

    Corrections: Correction

    Vol. 65, Issue 6, 2135, Version of Record online: 28 APR 2017

  20. You have free access to this content
    Incidence and Risk of Sorafenib-Induced Hypertension: A Systematic Review and Meta-Analysis

    The Journal of Clinical Hypertension

    Volume 16, Issue 3, March 2014, Pages: 177–185, Yan Li, Shun Li, Yaofeng Zhu, Xinyue Liang, Hui Meng, Jun Chen, Dongqing Zhang, Hu Guo and Benkang Shi

    Version of Record online : 12 MAR 2014, DOI: 10.1111/jch.12273